Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
16 11 2021
Historique:
pubmed: 21 10 2021
medline: 4 3 2022
entrez: 20 10 2021
Statut: ppublish

Résumé

Background Data on rehospitalizations for heart failure (HF) in Asia are scarce. We sought to determine the burden and predictors of HF (first and recurrent) rehospitalizations and all-cause mortality in patients with HF and preserved versus reduced ejection fraction (preserved EF, ≥50%; reduced EF, <40%), in the multinational ASIAN-HF (Asian Sudden Cardiac Death in Heart Failure) registry. Methods and Results Patients with symptomatic (stage C) chronic HF were followed up for death and recurrent HF hospitalizations for 1 year. Predictors of HF hospitalizations or all-cause mortality were examined with Cox regression for time to first event and other methods for recurrent events analyses. Among 1666 patients with HF with preserved EF (mean age, 68±12 years; 50% women), and 4479 with HF with reduced EF (mean age, 61±13 years; 22% women), there were 642 and 2302 readmissions, with 28% and 45% attributed to HF, respectively. The 1-year composite event rate for first HF hospitalization or all-cause death was 11% and 21%, and for total HF hospitalization and all-cause death was 17.7 and 38.7 per 100 patient-years in HF with preserved EF and HF with reduced EF, respectively. In HF with preserved EF, consistent independent predictors of these clinical end points included enrollment as an inpatient, Southeast Asian location, and comorbid chronic kidney disease or atrial fibrillation. The same variables were predictive of outcomes in HF with reduced EF except atrial fibrillation, and also included Northeast Asian location, older age, elevated heart rate, decreased systolic blood pressure, diabetes, smoking, and non-usage of beta blockers. Conclusions One-year HF rehospitalization and mortality rates were high among Asian patients with HF. Predictors of outcomes identified in this study could aid in risk stratification and timely interventions. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01633398.

Identifiants

pubmed: 34666509
doi: 10.1161/JAHA.121.021414
pmc: PMC8751971
doi:

Banques de données

ClinicalTrials.gov
['NCT01633398']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e021414

Références

JACC Heart Fail. 2014 Jun;2(3):289-97
pubmed: 24952697
JACC Heart Fail. 2020 Jan;8(1):12-21
pubmed: 31606361
Eur J Heart Fail. 2014 Jan;16(1):33-40
pubmed: 24453096
Circ J. 2004 May;68(5):427-34
pubmed: 15118283
Eur J Heart Fail. 2019 Jan;21(1):23-36
pubmed: 30113120
J Cardiovasc Med (Hagerstown). 2015 Sep;16(9):583-90
pubmed: 25022929
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
Eur J Heart Fail. 2013 Aug;15(8):928-36
pubmed: 23568645
Int J Cardiol. 2015 Mar 15;183:33-8
pubmed: 25662051
Circ J. 2009 Aug;73(8):1442-7
pubmed: 19521016
Clin Med Insights Cardiol. 2018 Jan 08;12:1179546817751609
pubmed: 29343997
Circ Heart Fail. 2014 Jul;7(4):590-5
pubmed: 24874200
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):333-42
pubmed: 23685625
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
JAMA. 2008 Jul 23;300(4):431-3
pubmed: 18647986
Lancet. 2015 Feb 28;385(9970):812-24
pubmed: 25467564
Eur Heart J. 2008 Feb;29(3):413-21
pubmed: 18245122
Circulation. 2015 Jan 6;131(1):43-53
pubmed: 25406306
Clin Cardiol. 2014 May;37(5):312-21
pubmed: 24945038
J Am Heart Assoc. 2020 Jan 7;9(1):e012199
pubmed: 31852421
Eur J Heart Fail. 2008 Feb;10(2):149-56
pubmed: 18279770
Eur J Heart Fail. 2016 Jun;18(6):613-25
pubmed: 27324686
Korean Circ J. 2017 May;47(3):341-353
pubmed: 28567084
Clin Cardiol. 2009 Jan;32(1):47-52
pubmed: 19143005
Eur Heart J. 2016 Nov 01;37(41):3141-3153
pubmed: 27502121
Biometrics. 2000 Jun;56(2):554-62
pubmed: 10877316
Circ Heart Fail. 2013 Mar;6(2):184-92
pubmed: 23258572
World J Cardiol. 2012 Feb 26;4(2):23-30
pubmed: 22379534
Eur Heart J. 2018 May 21;39(20):1770-1780
pubmed: 29390051

Auteurs

Wan Ting Tay (WT)

National Heart Centre Singapore Singapore.

Tiew-Hwa Katherine Teng (TK)

National Heart Centre Singapore Singapore.
Duke-National University of Singapore Medical School Singapore.
School of Population & Global Health University of Western Australia Perth Australia.

Oliver Simon (O)

Novartis (Singapore) Pte Ltd Singapore.

Wouter Ouwerkerk (W)

National Heart Centre Singapore Singapore.
Department of Dermatology University of Amsterdam Medical Centre Amsterdam the Netherlands.

Jasper Tromp (J)

National Heart Centre Singapore Singapore.
Duke-National University of Singapore Medical School Singapore.
University Medical Centre Groningen, University of Groningen Department of Cardiology Groningen the Netherlands.

Robert N Doughty (RN)

Faculty of Medicine and Health Sciences University of Auckland Auckland New Zealand.
Auckland City Hospital Auckland New Zealand.

A Mark Richards (AM)

National University Heart Centre Singapore.
University of Otago Dunedin New Zealand.

Chung-Lieh Hung (CL)

Mackay Memorial Hospital Taipei Taiwan.

Yan Qin (Y)

Department of Internal Medicine Singapore General Hospital Singapore.

Than Aung (T)

Department of Internal Medicine Singapore General Hospital Singapore.

Inder Anand (I)

Veterans Affairs Medical Center University of Minnesota Minneapolis MN.

Carolyn S P Lam (CSP)

National Heart Centre Singapore Singapore.
Duke-National University of Singapore Medical School Singapore.
University Medical Centre Groningen, University of Groningen Department of Cardiology Groningen the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH